Taiko Pharmaceutical Co.,ltd. Forecast, price target & analysts
Taiko Pharmaceutical Co.,ltd. Target price 2026 - Analyst rating & recommendation
Taiko Pharmaceutical Co.,ltd. Classifications & Recommendation
Taiko Pharmaceutical Co.,ltd. Price Target
| Target Price | ¥3,366.00 |
| Price | ¥264.00 |
| Potential |
1,175.00%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Taiko Pharmaceutical Co.,ltd. 2027 .
The average Taiko Pharmaceutical Co.,ltd. target price is ¥3,366.00.
This is
1,175.00%
register free of charge
¥3,465.00
1,212.50%
register free of charge
¥3,333.00
1,162.50%
register free of charge
|
|
| A rating was issued by 7 analysts: 0 Analysts recommend Taiko Pharmaceutical Co.,ltd. to buy, 3 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Taiko Pharmaceutical Co.,ltd. stock has an average upside potential 2027 of
1,175.00%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 6.40 | 6.37 |
| 1.67% | 0.38% | |
| EBITDA Margin | 11.32% | 6.18% |
| 19.53% | 45.40% | |
| Net Margin | 14.43% | 1.44% |
| 1.10% | 90.02% |
2 Analysts have issued a sales forecast Taiko Pharmaceutical Co.,ltd. 2026 . The average Taiko Pharmaceutical Co.,ltd. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Taiko Pharmaceutical Co.,ltd. EBITDA forecast 2026. The average Taiko Pharmaceutical Co.,ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Taiko Pharmaceutical Co.,ltd. Analysts have issued a net profit forecast 2026. The average Taiko Pharmaceutical Co.,ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 18.37 | 1.82 |
| 2.68% | 90.09% | |
| P/E | 142.46 | |
| EV/Sales | 1.53 |
2 Analysts have issued a Taiko Pharmaceutical Co.,ltd. forecast for earnings per share. The average Taiko Pharmaceutical Co.,ltd. EPS is
This results in the following potential growth metrics and future valuations:
Taiko Pharmaceutical Co.,ltd....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
